Upifitamab 2254118-43-7, sometimes called to as Mosunetuzumab, is an significant advance in the therapy field. This the CD20-directed antibody conjugate designed for targeted introduction of radioactive payloads https://anyaurtl087911.wikiinside.com/3954438/antibody_2254118_43_7_a_novel_new_antibody_drug